SEC Filing Madrigal Pharmaceuticals.
By A Mystery Man Writer
Madrigal Pharmaceuticals (NASDAQ:MDGL) Lowered to Sell at B. Riley - Defense World
EDGAR Filing Documents for 0001193125-24-068170
Madrigal Pharmaceuticals Inc - DEF 14A - Proxy Statement - May 01, 2023
Madrigal Pharmaceuticals Inc Trademarks & Logos
Madrigal Shares Skyrocket After Successful NASH Study
SEC Filing NeuroBo Pharmaceuticals, Inc.
B. Riley Securities Downgrades Madrigal Pharmaceuticals (MDGL)
EDGAR Filing Documents for 0001193125-24-068170
SEC Filing Terns Pharmaceuticals, Inc.
MDGL / Madrigal Pharmaceuticals, Inc. - Put/Call Ratio, Options Sentiment, Unusual Options Activity
SEC Filing Madrigal Pharmaceuticals.
